Minimally Invasive Treatment Methods for Pilonidal Disease

Not Applicable

Completed

• Conditions: Pilonidal Sinus

• Registration Number: NCT03070028
• Lead Sponsor: Uşak University

Brief Summary

Patients with pilonidal sinus disease will be randomised to two groups (crystallised phenol and platelet rich plasma). Sinus healing time, patient satisfaction, complications and recurrence rates will be compared.

Detailed Description

Patients with pilonidal sinus disease will be treated by either crystallised phenol or platelet rich plasma application. Treatment results, healing time, postprocedural complications, patient satisfaction and recurrences will be compared.

Study Timeline

• Study Start: 2017-01-01
• Study First Submitted: 2017-02-28
• Study First Submitted QC: 2017-02-28
• Study First Posted: 2017-03-03
• Primary Completion: 2019-12-01
• Status Verified: 2020-05
• Study Completion: 2020-05-01
• Last Update Submitted: 2020-05-11
• Last Update Posted: 2020-05-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Having pilonidal sinus disease
• accepting to be involved in the study

Exclusion Criteria

• below the age of 18
• having connective tissue disorders
• diabetes mellitus
• severe anemia

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
healing time	first 1 year of the study	Time to complete closure of the sinus cavity.

Trial Locations

Locations (1)

Uşak University; 🇹🇷 Uşak, Turkey